Oriola-KD Corporation Stock Exchange Release 16 December 2011 at 8.30 a.m. Guidelines issued on 19 July 2011 Oriola-KD's net sales are expected to increase over 10 per cent in 2011 compared to the previous year. Operating profit excluding one-off items and impairment charges is expected to exceed EUR 20 million in 2011. New guidelines issued on 16 December 2011 Oriola-KD's net sales are expected to increase approximately 11 per cent in 2011 compared to the previous year. Operating profit excluding one-off items and impairment charges is expected to be EUR 12-15 million in 2011. The operating loss of the pharmaceutical businesses in Russia, and especially of pharmaceutical wholesale, for the full year 2011 decreases significantly Oriola- KD's operating profit in 2011. Oriola-KD Corporation Eero Hautaniemi President and CEO Kimmo Virtanen Executive Vice President and CFO Further information: Kimmo Virtanen Executive Vice President and CFO tel. +358 (0)10 429 2069 e-mail: kimmo.virtanen@oriola-kd.com Pellervo Hämäläinen Vice President, Communications and Investor Relations tel. +358 (0)10 429 2497 e-mail: pellervo.hamalainen@oriola-kd.com Distribution NASDAQ OMX Helsinki Ltd Principal media Published by: Oriola-KD Corporation Corporate Communications Orionintie 5 FI-02200 Espoo, Finland www.oriola-kd.com [HUG#1571888]